First Opinion By Danielle Wenner and Gabriela Arguedas Ramírez Omitting long Covid from pandemic messaging is harmful for public health
First Opinion By Joe Lieberman and Michelle McMurry-Heath Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures
Hospitals By Tara Bannow Life or death decisions and no feedback: New study highlights the value of patient tracking, especially in the ER
Pharmalot By Ed Silverman Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program
Biotech By Allison DeAngelis Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
Pharmalot By Ed Silverman Drug spending increase slowed to 5.2 percent last year, Express Scripts says